N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16020580.
- Also identified by PMC identifier 1769030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dose and route of administration of N-acetylcysteine are key factors to consider when evaluating whether this agent is effective in preventing radiocontrast induced nephropathy.
Medical subject headings
- Acetylcysteine
- Contrast Media
- Kidney Diseases